Kinetic Model for FGF, FGFR, and Proteoglycan Signal Transduction Complex Assembly
- 30 March 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Biochemistry
- Vol. 43 (16), 4724-4730
- https://doi.org/10.1021/bi0352320
Abstract
The current working model for fibroblast growth factor receptor (FGFR) dimerization and activation requires the assembly of a ternary complex of fibroblast growth factor (FGF), FGFR, and heparin or heparan sulfate proteoglycan (HSPG) on the plasma membrane. The recent FGF2−FGFR1−heparin crystal structure provides a detailed but static view of the FGF−FGFR−heparin complex. However, the kinetics of ternary complex assembly has yet to be investigated. Here, we characterize FGF2, FGFR1, and heparin interactions using surface plasmon resonance (SPR). Binding constants for binary FGF2/FGFR1 (KD = 62 nM), FGF2/heparin (KD = 39 nM), and FGFR1/heparin (KD = 3.2 μM) interactions correlate to the magnitude of binding interface observed in the FGF2−FGFR1−heparin crystal structure. Interestingly, comparison of sensorgrams of sequential injections of FGF2 and FGFR1 and equimolar FGF2−FGFR1 injections onto a heparin neoproteoglycan surface demonstrates that FGF2 dramatically enhances the association of FGFR1 with heparin and leads us to propose a model for the stepwise assembly of a ternary FGF−FGFR−HSPG complex. The weak binding affinity of the FGFR1−heparin interaction suggests that in this model, FGFR and HSPG are unbound in the absence of FGF ligand. The availability of FGF results in formation of initial FGF−HSPG complexes, which promotes the rapid binding of FGFR and creates a ternary complex capable of undergoing dimerization and subsequent FGFR activation. In contrast, alternative models for the kinetic assembly of a ternary complex in which binary FGF−FGFR or FGFR−HSPG complexes are intermediates do not conform well with the experimental data.Keywords
This publication has 8 references indexed in Scilit:
- Biochemical analysis of pathogenic ligand-dependent FGFR2 mutations suggests distinct pathophysiological mechanisms for craniofacial and limb abnormalitiesHuman Molecular Genetics, 2004
- Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblastsBiochemical Journal, 2002
- The influence of transport on the kinetics of binding to surface receptors: application to cells and BIAcoreJournal of Molecular Recognition, 1999
- Interactions of putative heparin-binding domains of basic fibroblast growth factor and its receptor, FGFR-1, with heparin using synthetic peptides.Glycoconjugate Journal, 1998
- Receptor Specificity of the Fibroblast Growth Factor FamilyJournal of Biological Chemistry, 1996
- Multivalent Ligand-Receptor Binding Interactions in the Fibroblast Growth Factor System Produce a Cooperative Growth Factor and Heparin Mechanism for Receptor DimerizationBiochemistry, 1994
- High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cellsJournal of Cellular Physiology, 1987
- The identification and partial characterization of the fibroblast growth factor receptor of baby hamster kidney cells.Journal of Biological Chemistry, 1985